Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors

NCT03129139 is registered in ClinicalTrials.gov with Minneamrita Therapeutics LLC as lead sponsor.

NCT NCT03129139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03129139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors
Lead sponsor
Minneamrita Therapeutics LLC
Phase
Phase 1
Overall status
Unknown status
Start date
October 10, 2017
Completion date
December 1, 2024
Enrollment
66 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, breast cancer, cancer of stomach, colo-rectal cancer, gastric cancer, pancreatic cancer, prostate cancer metastatic, solid carcinoma, solid carcinoma of stomach, solid tumor